Skip to main content
Premium Trial:

Request an Annual Quote

Marina Defaults on Loan as Bankruptcy Looms

Premium

Troubled RNAi drug developer Marina Biotech this week disclosed that it has defaulted in making repayments of outstanding secured indebtedness, putting further pressure on the company as it skirts bankruptcy.

Struggling under a cash shortage, Marina halted virtually all of its operations in mid-2012 (GSN 6/7/2012). Later that year, it released its long-delayed 2011 financial results, reporting that its funds were expected to run out before the end of that year.

Marina has managed to squeak by after selling off all of its equipment and terminating almost all of its employees. In a filing with the US Securities and Exchange Commission this week, the company said it now expects its cash to last through the end of February.

However, this assumes successful negotiations with its lenders, Marina said in the filing.

In February 2012, the company issued 15 percent secured promissory notes in the aggregate principal amount of $1.5 million to two investors, it said. The notes were due and payable by the end of 2012.

“We are currently in default in the repayment of these notes,” Marina noted in the filing. “As a result, the secured lenders may foreclose on substantially all of our assets under the notes and the related security agreements.

“Renegotiations of the debt agreements to address the default are ongoing,” it added.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.